PUBLISHER: Grand View Research | PRODUCT CODE: 1630980
PUBLISHER: Grand View Research | PRODUCT CODE: 1630980
The global intra-abdominal pressure measurement devices market size is anticipated to reach USD 250.6 million in 2030 and is projected to grow at a CAGR of 8.2% from 2025 to 2030. Increasing incidence of Intra-abdominal Hypertension (IAH), Abdominal Compartment Syndrome (ACS), and rapid technological advancements are driving the market.
Elevated Intra-abdominal Pressure (IAP) affects the organ functionality in critically ill patients and this may lead to Abdominal Compartment Syndrome (ACS). There is high prevalence of IAH and ACS among patients in intensive care units across the world. The incidence of IAH and ACS is associated with significantly increased mortality and morbidity. The rise in IAP causes tissue hypoperfusion which can lead to impaired hepatic blood flow, multiple organ dysfunction syndromes, respiratory failure, increased intracranial pressure, renal failure, and impair the function of nearly every organ.
Technological advancements such as, development of digital and wireless IAP monitors to improve conditions of critically ill patients. For instance, Potrero Medical's Accuryn Monitoring System helps to precisely monitor patients' vital signs in real-time and integrates with the hospital EMR system. This system can transform a traditional Foley catheter into a next-generation diagnostic tool that can automatically measure urine output, IAP, and core body temperature. In addition, ConvaTec's AbViser AutoValve IAP Monitoring Device automatically integrates with all Foley catheters, transducers, and patient monitors in any ICU or operation room.
The muscle segment is anticipated to witness highest CAGR over the forecast period. This is attributed to rising cases of burns, trauma, sport injuries, abdominal surgeries. It results in large amount of oppression inside a muscle compartment causing swelling, pain, and sometimes disability in the affected muscles, thereby driving the market.